Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production

European Journal of Cardio-thoracic Surgery

Volumn 35, Issue 5, 2009, Pages 839-846

  Mihov, Deyan ^b   Bogdanov, Nikolay ^b   Grenacher, Beat ^b   Gassmann, Max ^b,c   Zünd, Gregor ^a   Bogdanova, Anna ^b,c   Tavakoli, Reza ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Erythropoietin; Myocardial ischemia reperfusion injury

Indexed keywords

CASPASE 3; CASPASE 9; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; NITRITE; RECOMBINANT ERYTHROPOIETIN; TROPONIN T;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOPLEGIA; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DRUG BINDING SITE; DRUG EFFECT; DRUG MECHANISM; EX VIVO STUDY; EXPERIMENTAL MODEL; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART SURGERY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEWIS RAT; MALE; NICK END LABELING; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; ATRIAL NATRIURETIC FACTOR; BODY WATER; CARDIOTONIC AGENTS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ENDOTHELIUM, VASCULAR; ERYTHROPOIETIN, RECOMBINANT; HEART TRANSPLANTATION; MALE; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, INBRED LEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TROPONIN T;

EID: 64749104944     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.12.049     Document Type: Article

References (23)

1. Murphy E., and Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88 (2008) 581-609
2. Bolli R., Becker L., Gross G., Mentzer Jr. R.M., Balshaw D., and Lathrop D.A. Myocardial protection at a crossroads. The need for translation into clinical therapy. Circ Res 95 (2004) 125-134
3. Arcasoy M.O. The non-haematopoietic biological effects of erythropoietin. Br J Haematol 141 (2008) 14-31
4. Junk A.K., Mammis A., Saviz S.I., Singh M., Roth S., Malhotra S., Rosenbaum P.S., Cerami A., Brines M., and Rosenbaum D.M. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A 99 (2002) 10659-10664
5. Wang Y., Zhang Z.G., Rhodes K., Renzi M., Zhang R.L., Kapke A., Lu M., Pool C., Heavner G., and Chopp M. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia. Br J Pharmacol 151 (2007) 1377-1384
6. Wright G.L., Hanlon P., Amin K., Steenbergen C., Murphy E., and Arcasoy M.O. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. FASEB J 18 (2004) 1031-1033
7. Ono K., and Lindsey E.S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 57 (1969) 225-229
8. Bombeli T., Schwartz B.R., and Harlan J.M. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood 93 (1999) 3831-3838
9. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27 (1969) 502-522
10. Schafer B.W., and Perriard J.C. Intracellular targeting of isoproteins in muscle cytoarchitecture. J Cell Biol 106 (1988) 1161-1170
11. Tavakoli R., Gazdhar A., Pierog J., Bogdanova A., Gugger M., Pringle I.A., Gill D.R., Hyde S.C., Genoni M., and Schmid R.A. Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts. J Gene Med 8 (2006) 242-248
12. Moon C., Krawczyk M., Paik D., Lakatta E.G., and Talan M.I. Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window. Cardiovasc Drugs Ther 19 (2005) 243-250
13. Bullard A.J., Govewalla P., and Yellow D.M. Erythropoietin protects the myocardium against reperfusion injury in vitro an in vivo. Basic Res Cardiol 100 (2005) 397-403
14. Parsa C.J., Kim J., Riel R.U., Pascal L.S., Walton G.B., Thompson R.B., Petrofski J.A., Matsumoto A., Stamler J., and Koch W.J. Cardioprotective effects of erythropoietin in the reperfused ischemic heart. A potential role for cardiac fibroblasts. J Biol Chem 279 (2004) 20655-20662
15. Tramontano A.F., Muniyappa R., Black A.D., Blendea M.C., Cohen I., Deng L., Sowers J.R., Cutaia M.V., and El-Sherif N. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun 308 (2003) 990-994
16. Hanlon P.R., Fu P., Wright G.L., Steenbergen C., Arcasoy M.O., and Murphy E. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol-3-kinase signalling. FASEB J 19 (2005) 1323-1325
17. Piuhola J., Kerkela R., Keenan J.I., Hampton M.B., Richards A.M., and Pemberton C.J. Direct cardiac actions of erythropoietin (EPO): effects on cardiac contractility. BNP secretion and ischaemia/reperfusion injury. Clin Sci (Lond) 114 (2008) 293-304
18. van der Meer P., Lipsic E., Henning R.H., de Boer R.A., Suurmeijer A.J.H., van Veldhuisen D.J., and van Gilst W.H. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury. Eur J Heart Fail 6 (2004) 853-859
19. van der Meer P., Lipsic E., Henning R.H., Boddeus K., van der Velden J., Voors A.A., van Veldhuisen D.J., van Gilst W.H., and Schoemaker R.G. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J Am Coll Cardiol 46 (2005) 125-133
20. Scarabelli T., Stephanou A., Rayment N., Pasini E., Comini L., Curello S., Ferrari R., Knight R., and Latchman D. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 104 (2001) 253-256
21. Burger D., Lei M., Geoghegan-Morphet N., Lu X., Xenocostas A., and Feng Q. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovasc Res 72 (2006) 51-59
22. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87 (2007) 315-424
23. Petrushanko I.Y., Bogdanov N.B., Lapina N., Boldyrev A.A., Gassmann M., and Bogdanova A.Y. Oxygen-induced regulation of Na/K ATPase in cerebellar granule cells. J Gen Physiol 130 (2007) 389-398